Combination therapy with low-dose teriparatide and zoledronate contributes to fracture healing on rat femoral fracture model

J Orthop Surg Res. 2018 Oct 25;13(1):267. doi: 10.1186/s13018-018-0917-8.

Abstract

Background: Delay in fracture healing or non-union can be devastating complication. Recent studies have reported that teriparatide (TP) demonstrated effectively on callus formation and mechanical strength and zoledronate (ZA) increased the callus size and resistance at the fracture site in rat fracture model. In this study, the effects of combination therapy with low dose TP and ZA on fracture healing was evaluated.

Methods: From 1 week post-operation, TP (5 times a week administration) and ZA (0.1 mg/kg single administration) were administered by dividing the rats into the following five groups: TP 1 μg group {T(1): TP 1 μg/kg}, ZA group (ZA:0.1 mg/kg), TP1 μg+ZA group {T(1)+ZA: TP 1 μg/kg+ZA}, TP 10 μg+ZA group {T(10)+ZA: TP 10 μg/kg + ZA}, and control group (C: administered saline). Rt femurs were excised 7 weeks after the surgery; bone fusions were evaluated with soft X-ray images on a 4-point scale. And the histopathological examination was performed in demineralized and non-demineralized specimens. Furthermore, the Radiographic Union Scale was conducted in all specimens.

Results: About the bone fusions rates, C, T(1), ZA, T(1)+ZA, and T(10)+ZA groups demonstrated 20.0%, 55.6%, 70.0%, 70.0%, and 80.0%, respectively, and with 4-point scale, each group was 0.50, 1.56, 2.00, 2.60, and 2.80 points, respectively. The callus volume was significantly increased to 16.66 mm2 and 17.75 mm2 in the T(1)+ZA and T(10)+ZA groups, respectively, while 10.65 mm2 (p < 0.05) in the C group. Furthermore, the callus area in the T(10)+ZA group was also observed to have significantly increased to 78.78%, compared with 54.63% and 44.11% in the C and T(1)+ZA groups, respectively (p < 0.01). Histopathologically, cartilage tissue and immature callus formation were observed at the bone junction in the C group; however, the osseous bridge formation of mature callus was observed in the ZA, T(1)+ZA, and T(10)+ZA groups.

Conclusion: It is suggested that administration of low dose TP and ZA in combination may lead to the treatment of delayed union of fracture. We hope the combination treatment may become one of new therapeutic strategy.

Keywords: Fracture healing; Teriparatide; Zoledronate.

MeSH terms

  • Animals
  • Bone Density Conservation Agents / administration & dosage
  • Bone Density Conservation Agents / pharmacology
  • Bone Density Conservation Agents / therapeutic use*
  • Bony Callus / drug effects
  • Bony Callus / pathology
  • Disease Models, Animal
  • Drug Administration Schedule
  • Drug Evaluation, Preclinical / methods
  • Drug Therapy, Combination
  • Femoral Fractures / diagnostic imaging
  • Femoral Fractures / drug therapy*
  • Femoral Fractures / pathology
  • Femoral Fractures / physiopathology
  • Fracture Healing / drug effects*
  • Male
  • Radiography
  • Rats, Sprague-Dawley
  • Teriparatide / administration & dosage
  • Teriparatide / pharmacology
  • Teriparatide / therapeutic use*
  • Zoledronic Acid / administration & dosage
  • Zoledronic Acid / pharmacology
  • Zoledronic Acid / therapeutic use*

Substances

  • Bone Density Conservation Agents
  • Teriparatide
  • Zoledronic Acid

Grants and funding